Amid surging covid cases globally, the latest vaccine development from Australia comes in as a blow for markets, as the OZ nation’s most populous state of New South Wales (NSW) has paused all AstraZeneca vaccinations.
“The NSW government has temporarily suspended the administration of the AstraZeneca vaccine to all age groups after Australian medical experts warned of its rare but potential blood clotting side effects. “
“State authorities are awaiting updated consent information.”
“AstraZeneca vaccinations for those aged 50 years and over would recommence later on Friday, after the informed consent information was updated.”
“The state government said the Pfizer vaccine would continue to be administered at NSW Health clinics.”
The renewed selling pressure seen in the AUD/USD pair could be also attributed to this piece of news alongside the mixed Chinese inflation data and RBA’s warning.
The aussie was last seen trading at 0.7639, down 0.16% on the day.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.